A single-center review of pre-exposure prophylaxis with tixagevimab-cilgavimab in solid organ transplant recipients
Description
BACKGROUND: Coronavirus disease 2019 (COVID-19) continues to negatively impact solid organ transplant recipients (SOTr). Data on the use of tixagevimab-cilgavimab (tix-cil) in vaccinated SOTr during circulation of Omicron and its subvariants are